Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Sep 1;85(9):1396–1399. doi: 10.1054/bjoc.2001.2102

AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma

E Rivera 1, O Arrieta 1,2, P Guevara 1, A Duarte-Rojo 2, J Sotelo 1,2
PMCID: PMC2375243  PMID: 11720480

Abstract

Malignancy of neoplasms is partly dependent on angiogenesis. Angiotensin II mediates angiogenesis and transcription of growth-related factors through stimulation of the AT1 receptor (AT1R). Losartan, a drug used mostly for treatment of hypertension, binds strongly to this receptor. We found the presence of AT1 receptor on C6 glioma cells and studied the effect of Losartan on the growth and angiogenesis of C6 rat glioma; Losartan in dose of 80 mg/kg induced 79% reduction of tumoural volume with a significant decrease of vascular density, mitotic index and cell proliferation. Our results demonstrate the conspicuous presence of AT1R in malignant glial cells and a favourable therapeutic response in experimental glioma by selective blockage of the AT1 receptor. © 2001 Cancer Research Campaign  http://www.bjcancer.com

Keywords: Losartan, angiotensin, glioma, brain tumour, angiogenesis

Full Text

The Full Text of this article is available as a PDF (64.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arrieta O., Guevara P., Reyes S., Ortiz A., Rembao D., Sotelo J. Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine. Eur J Cancer. 1998 Dec;34(13):2101–2106. doi: 10.1016/s0959-8049(98)00244-5. [DOI] [PubMed] [Google Scholar]
  2. Burnier M. Angiotensin II type 1 receptor blockers. Circulation. 2001 Feb 13;103(6):904–912. doi: 10.1161/01.cir.103.6.904. [DOI] [PubMed] [Google Scholar]
  3. Chen L., Re R. N., Prakash O., Mondal D. Angiotensin-converting enzyme inhibition reduces neuroblastoma cell growth rate. Proc Soc Exp Biol Med. 1991 Mar;196(3):280–283. doi: 10.3181/00379727-196-43189. [DOI] [PubMed] [Google Scholar]
  4. Cheng S. Y., Huang H. J., Nagane M., Ji X. D., Wang D., Shih C. C., Arap W., Huang C. M., Cavenee W. K. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8502–8507. doi: 10.1073/pnas.93.16.8502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  6. DeAngelis L. M. Brain tumors. N Engl J Med. 2001 Jan 11;344(2):114–123. doi: 10.1056/NEJM200101113440207. [DOI] [PubMed] [Google Scholar]
  7. Fernandez L. A., Twickler J., Mead A. Neovascularization produced by angiotensin II. J Lab Clin Med. 1985 Feb;105(2):141–145. [PubMed] [Google Scholar]
  8. Fournier A., Ghitu A., Darabont R., Mazouz H., Makdassi R., Canaple S., Rosa A., Fernandez L. A. Dualité des récepteurs de l'angiotensine II et risque d'accidents vasculaires cérébraux et de cancer: quels liens entre eux? Presse Med. 1999 May 1;28(17):918–922. [PubMed] [Google Scholar]
  9. Fujimoto Y., Sasaki T., Tsuchida A., Chayama K. Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett. 2001 Apr 27;495(3):197–200. doi: 10.1016/s0014-5793(01)02377-8. [DOI] [PubMed] [Google Scholar]
  10. González-Espinosa C., García-Sáinz J. A. Angiotensin II and active phorbol esters induce proto-oncogene expression in isolated rat hepatocytes. Biochim Biophys Acta. 1992 Sep 9;1136(3):309–314. doi: 10.1016/0167-4889(92)90122-r. [DOI] [PubMed] [Google Scholar]
  11. Guevara P., Sotelo J. C6 rat glioma grown into the peritoneal cavity, a large source of tumoral cells for subcutaneous transplant of glioma. J Neurooncol. 1999 Aug;44(1):91–92. doi: 10.1023/a:1006112422132. [DOI] [PubMed] [Google Scholar]
  12. Hafizi S., Chester A. H., Allen S. P., Morgan K., Yacoub M. H. Growth response of human coronary smooth muscle cells to angiotensin II and influence of angiotensin AT1 receptor blockade. Coron Artery Dis. 1998;9(4):167–175. doi: 10.1097/00019501-199809040-00001. [DOI] [PubMed] [Google Scholar]
  13. Iwai N., Inagami T. Identification of two subtypes in the rat type I angiotensin II receptor. FEBS Lett. 1992 Feb 24;298(2-3):257–260. doi: 10.1016/0014-5793(92)80071-n. [DOI] [PubMed] [Google Scholar]
  14. Jensen R. L. Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review. Surg Neurol. 1998 Feb;49(2):189–196. doi: 10.1016/s0090-3019(97)00218-8. [DOI] [PubMed] [Google Scholar]
  15. Kawahara Y., Sunako M., Tsuda T., Fukuzaki H., Fukumoto Y., Takai Y. Angiotensin II induces expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 1988 Jan 15;150(1):52–59. doi: 10.1016/0006-291x(88)90485-8. [DOI] [PubMed] [Google Scholar]
  16. Kim K. J., Li B., Winer J., Armanini M., Gillett N., Phillips H. S., Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993 Apr 29;362(6423):841–844. doi: 10.1038/362841a0. [DOI] [PubMed] [Google Scholar]
  17. Leung K. H., Chang R. S., Lotti V. J., Roscoe W. A., Smith R. D., Timmermans P. B., Chiu A. T. AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes. Am J Hypertens. 1992 Sep;5(9):648–656. doi: 10.1093/ajh/5.9.648. [DOI] [PubMed] [Google Scholar]
  18. Lever A. F., Hole D. J., Gillis C. R., McCallum I. R., McInnes G. T., MacKinnon P. L., Meredith P. A., Murray L. S., Reid J. L., Robertson J. W. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet. 1998 Jul 18;352(9123):179–184. doi: 10.1016/S0140-6736(98)03228-0. [DOI] [PubMed] [Google Scholar]
  19. Lund E. L., Spang-Thomsen M., Skovgaard-Poulsen H., Kristjansen P. E. Tumor angiogenesis--a new therapeutic target in gliomas. Acta Neurol Scand. 1998 Jan;97(1):52–62. doi: 10.1111/j.1600-0404.1998.tb00609.x. [DOI] [PubMed] [Google Scholar]
  20. Plate K. H., Breier G., Risau W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol. 1994 Jul;4(3):207–218. doi: 10.1111/j.1750-3639.1994.tb00835.x. [DOI] [PubMed] [Google Scholar]
  21. Plate K. H., Breier G., Weich H. A., Mennel H. D., Risau W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer. 1994 Nov 15;59(4):520–529. doi: 10.1002/ijc.2910590415. [DOI] [PubMed] [Google Scholar]
  22. Roychowdhury D. F., Tseng A., Jr, Fu K. K., Weinburg V., Weidner N. New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression. Cancer. 1996 Apr 15;77(8):1419–1426. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1419::AID-CNCR1>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  23. Schmidt N. O., Westphal M., Hagel C., Ergün S., Stavrou D., Rosen E. M., Lamszus K. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer. 1999 Feb 19;84(1):10–18. doi: 10.1002/(sici)1097-0215(19990219)84:1<10::aid-ijc3>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  24. Siragy H. Angiotensin II receptor blockers: review of the binding characteristics. Am J Cardiol. 1999 Nov 18;84(10A):3S–8S. doi: 10.1016/s0002-9149(99)00727-4. [DOI] [PubMed] [Google Scholar]
  25. Stoll M., Meffert S., Stroth U., Unger T. Growth or antigrowth: angiotensin and the endothelium. J Hypertens. 1995 Dec;13(12 Pt 2):1529–1534. [PubMed] [Google Scholar]
  26. Stoll M., Steckelings U. M., Paul M., Bottari S. P., Metzger R., Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995 Feb;95(2):651–657. doi: 10.1172/JCI117710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wang D. H., Prewitt R. L. Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension. 1990 Jan;15(1):68–77. doi: 10.1161/01.hyp.15.1.68. [DOI] [PubMed] [Google Scholar]
  28. Wang D., Huang H. J., Kazlauskas A., Cavenee W. K. Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase. Cancer Res. 1999 Apr 1;59(7):1464–1472. [PubMed] [Google Scholar]
  29. Weidner N., Semple J. P., Welch W. R., Folkman J. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med. 1991 Jan 3;324(1):1–8. doi: 10.1056/NEJM199101033240101. [DOI] [PubMed] [Google Scholar]
  30. van der Valk P., Lindeman J., Kamphorst W. Growth factor profiles of human gliomas. Do non-tumour cells contribute to tumour growth in glioma? Ann Oncol. 1997 Oct;8(10):1023–1029. doi: 10.1023/a:1008265905505. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES